Progesteron only injection Flashcards
Progesteron only injection: How it works
Primarily by preventing ovulation
Progesteron only injection: Duration of use
Repeat injections needed every 12 weeks (DPMA) or 8 weeks (NET‑EN)
Progesteron only injection: Failure rate
- Fewer than 0.4 in 100 over 2 years
- Pregnancy rates lower for DPMA than NET‑EN
Progesteron only injection: Effect on periods
- Amenorrhoea common, and is more likely with DMPA than NET‑EN, and with longer use; not harmful
- Persistent bleeding may occur
Progesteron only injection: Other risks
- Up to 50% of women stop using DMPA by 1 year; the most common reason is an altered bleeding pattern, such as persistent bleeding
- Weight gain: may be up to 2–3 kg over a year on DMPA
- Bone mineral density: DMPA use is associated with small loss; largely recovered when DMPA is stopped
- No evidence that fracture risk is increased
-No evidence of effect of DMPA on:
Depression
Acne
Headaches
Progesteron only injection: Return of fertility
- Can take up to a year
- Women who do not want to get pregnant should start a different contraceptive as soon as they stop injections
Progesteron only injection: At the time of fitting
Return for next injection, or if problems
Progesteron only injection: population
- Avoid in adolescents, but it may be given if other methods are not suitable or acceptable
- Avoid in women older than 40 years, but in general the benefits outweigh the risks, and it may be given if other methods are not suitable or acceptable
- Women with a body mass index over 30 can safely use DMPA and NET‑EN
- Women who are breastfeeding can consider using injectable contraceptives
Progesteron only injection: timing of fitting
- Up to and including the fifth day of the menstrual cycle without the need for additional contraceptive protection
- At any other time in the menstrual cycle, but additional barrier contraception should be used for the first 7 days after the injection
- Immediately after first‑ or second‑trimester abortion, or at any time thereafter
- At any time post‑partum.
Progesteron only injection: f/up
- Women attending up to 2 weeks late for repeat injection of DMPA may be given the injection without the need for additional contraceptives
- A pattern of persistent bleeding associated with DMPA use can be treated with mefenamic acid or ethinylestradiol
- Women who wish to continue DMPA use beyond 2 years should have their individual clinical situations reviewed, the balance between the benefits and potential risks discussed, and be supported in their choice of whether or not to continue
- Healthcare professionals should be aware that if pregnancy occurs during DMPA use there is no evidence of congenital malformation to the fetus